Back to search
FDAFDA · Food and drugs·Recall number D-0483-2019

COSOPT Ophthalmic Solution, USP, (2% Dorzolamide Hydrochloride, 0.5% Timolol Maleate), 10 mL dropper bottle, Sterile, Rx only, Distributed by: Akorn, Inc., Lake Forest, IL, NDC: 17478-605-10

Published February 20, 2019 · Recall initiated: December 20, 2018

Summary

FDA records drug Class III recall D-0483-2019, published February 20, 2019 and initiated December 20, 2018. Recalling firm: Akorn Inc; Status: Terminated; Reported quantity: 30,794 bottles; Lot: Lots: 426007 and 426008, exp 4/2020. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications: out of specification results for opalescence at 7 month stability study.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Akorn Inc
Distributor
Nationwide USA and Puerto Rico
Lot
Lots: 426007 and 426008, exp 4/2020
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was COSOPT Ophthalmic Solution, USP, (2% Dorzolamide Hydrochloride, 0.5% Timolol Maleate), 10 mL dropper bottle, Sterile, Rx only, Distributed by: Akorn, Inc., Lake Forest, IL, NDC: 17478-605-10 recalled?

Yes. FDA published recall D-0483-2019 on February 20, 2019. Reported hazard: Failed Stability Specifications: out of specification results for opalescence at 7 month stability study.

What should I do if I have this product?

Voluntary: Firm initiated · Letter